SUPN · NASDAQ · Drug Manufacturers - Specialty & Generic

Supernus Pharmaceuticals (SUPN)

Develops CNS medicines spanning ADHD, Parkinson’s disease, postpartum depression, and epilepsy.

$43.96
vs last close+1.18 (+2.76%)